NANOG | Nanog homeobox | Transcription factors
| | | | | Tissue enhanced |
SLC2A14 | Solute carrier family 2 (facilitated glucose transporter), member 14 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SLC2A3 | Solute carrier family 2 (facilitated glucose transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
FOXJ2 | Forkhead box J2 | Transcription factors
| | | | | Expressed in all |
C3AR1 | Complement component 3a receptor 1 | G-protein coupled receptors Predicted membrane proteins
| | | | | Mixed |
NECAP1 | NECAP endocytosis associated 1 | | | | | | Expressed in all |
CLEC4A | C-type lectin domain family 4, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
ZNF705A | Zinc finger protein 705A | Transcription factors
| | | | | Tissue enriched |
FAM90A1 | Family with sequence similarity 90, member A1 | | | | | | Not detected |
CLEC6A | C-type lectin domain family 6, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4D | C-type lectin domain family 4, member D | Predicted membrane proteins
| | | | | Group enriched |
CLEC4E | C-type lectin domain family 4, member E | Predicted membrane proteins
| | | | | Tissue enhanced |
AICDA | Activation-induced cytidine deaminase | Disease related genes Enzymes Potential drug targets
| | | | | Group enriched |
MFAP5 | Microfibrillar associated protein 5 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RIMKLB | Ribosomal modification protein rimK-like family member B | Enzymes
| | | | | Expressed in all |
A2ML1 | Alpha-2-macroglobulin-like 1 | Predicted secreted proteins
| | | | | Tissue enriched |
PHC1 | Polyhomeotic homolog 1 (Drosophila) | Disease related genes
| | | | | Expressed in all |
M6PR | Mannose-6-phosphate receptor (cation dependent) | FDA approved drug targets Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
KLRG1 | Killer cell lectin-like receptor subfamily G, member 1 | Predicted membrane proteins
| | | | | Mixed |
A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
PZP | Pregnancy-zone protein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
KLRB1 | Killer cell lectin-like receptor subfamily B, member 1 | CD markers Predicted membrane proteins
| | | | | Mixed |
CLEC2D | C-type lectin domain family 2, member D | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
CLECL1 | C-type lectin-like 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CD69 | CD69 molecule | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KLRF1 | Killer cell lectin-like receptor subfamily F, member 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC2B | C-type lectin domain family 2, member B | Predicted secreted proteins
| | | | | Mixed |
KLRF2 | Killer cell lectin-like receptor subfamily F, member 2 | Predicted membrane proteins
| | | | | Not detected |
CLEC2A | C-type lectin domain family 2, member A | Predicted membrane proteins
| | | | | Tissue enriched |
CLEC12A | C-type lectin domain family 12, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC1B | C-type lectin domain family 1, member B | Predicted membrane proteins
| | | | | Tissue enriched |
CLEC12B | C-type lectin domain family 12, member B | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC9A | C-type lectin domain family 9, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC1A | C-type lectin domain family 1, member A | Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC7A | C-type lectin domain family 7, member A | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM52B | Transmembrane protein 52B | Predicted secreted proteins
| | | | | Tissue enriched |
GABARAPL1 | GABA(A) receptor-associated protein like 1 | | | | | | Expressed in all |
KLRD1 | Killer cell lectin-like receptor subfamily D, member 1 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KLRK1 | Killer cell lectin-like receptor subfamily K, member 1 | Cancer-related genes CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KLRC4-KLRK1 | KLRC4-KLRK1 readthrough | Predicted membrane proteins
| | | | | Mixed |
KLRC4 | Killer cell lectin-like receptor subfamily C, member 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
KLRC3 | Killer cell lectin-like receptor subfamily C, member 3 | Predicted membrane proteins
| | | | | Tissue enhanced |
NKG2-E | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
KLRC2 | Killer cell lectin-like receptor subfamily C, member 2 | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
KLRC1 | Killer cell lectin-like receptor subfamily C, member 1 | CD markers Predicted membrane proteins
| | | | | Mixed |
EIF2S3L | Putative eukaryotic translation initiation factor 2 subunit 3-like protein | | | | | | Expressed in all |
MAGOHB | Mago-nashi homolog B (Drosophila) | | | | | | Expressed in all |
STYK1 | Serine/threonine/tyrosine kinase 1 | Enzymes Predicted membrane proteins
| | | | | Mixed |
YBX3 | Y box binding protein 3 | Transcription factors
| | | | | Expressed in all |